Lifeblood, the Thrombosis Charity was founded in 2002 by Professor Beverley Hunt, Consultant Haematologist at Guy's and St Thomas' NHS Foundation Trust and Professor Alan Moody, Professor of Radiology at Nottingham University to address two important issues: improving medical and general knowledge of thrombosis, and raising funds for research into thrombosis.
In 2003, the charity started campaigning to raise awareness. They founded the yearly National Thrombosis Week and provided evidence on several health select committees. They also won the title of 'Health Charity of the Year' in 2010.
In the same year, Lifeblood published the results of a conducted survey which showed that there is a big education gap concerning hospital acquired blood clots.
In 2010, on behalf of Lifeblood, Professor Hunt was included as a member of the guideline development group for the National Institute for Health and Clinical Excellence (NICE) guidelines in which mandatory thrombosis risk assessment of all patients on admission was set as a must for all National Health Service (NHS) hospitals.
2010 Life Blood published the Venous Thromboembolism Challenge in Scotland, A report into VTE prevention in Scottish Health Boards. Presented at a meeting in the Scottish Parliament hosted by Trish Godman MPS, in March 2010.
2016, an updated report on the VTE Prevention in Scottish Health Boards was sent to NHS Scotland with data sourced from Freedom of Information requests.
2019 Professor Beverley Hunt, Founder and Medical Lead of Thrombosis UK, was awarded an OBE in the Queen’s Birthday Honours for her services to medicine.
The 'Stop the Clots' campaign aims to ensure that every adult patient admitted to hospital across the UK receives a venous thromboembolism risk assessment and appropriate prophylaxis in line with national clinical guidelines (SIGN Clinical Guideline in Scotland, and NICE Clinical Guideline 92 in England, Wales and Northern Ireland). The House of Commons welcomed the parliamentary launch of Lifeblood: The Thrombosis Charity and commended its campaign to Stop the Clots in 2003.
Lifeblood provided both written and oral evidence on several Health Committees: